Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

EGFR ACTIVATING MUTATION

Clinical trials for EGFR ACTIVATING MUTATION explained in plain language.

Never miss a new study

Get alerted when new EGFR ACTIVATING MUTATION trials appear

Sign up with your email to follow new studies for EGFR ACTIVATING MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1
Sort by
  • New dosing strategy aims to tackle lung cancer brain spread

    Disease control Recruiting now

    This study is for people with a specific type of advanced lung cancer (EGFR-mutant NSCLC) that has spread to the lining of the brain (leptomeningeal metastasis). It tests whether taking a higher dose of the drug furmonertinib every other day works better and is safe compared to t…

    Matched conditions: EGFR ACTIVATING MUTATION

    Phase: NA • Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Disease control

    Last updated May 07, 2026 18:39 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space